In AD, phosphorylated tau is misfolded and eventually recruits molecular chaperones Hsc70/HSP70 and HSP90 and their co-chaperones BAG-1 and FKBP51 to prevent tau aggregation or disease progression. This evidence concerns the gene MAPT and Alzheimer disease.